You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 19, 2026

Litigation Details for Headwater Research LLC v. SAMSUNG ELECTRONICS CO., LTD. (E.D. Tex. 2023)


✉ Email this page to a colleague

« Back to Dashboard


Headwater Research LLC v. SAMSUNG ELECTRONICS CO., LTD. (E.D. Tex. 2023)

Docket 2:23-cv-00641 Date Filed 2023-12-29
Court District Court, E.D. Texas Date Terminated
Cause 35:271 Patent Infringement Assigned To James Rodney Gilstrap
Jury Demand Both Referred To Roy S. Payne
Patents 11,040,004; 9,000,021; 9,056,052
Link to Docket External link to docket
Small Molecule Drugs cited in Headwater Research LLC v. SAMSUNG ELECTRONICS CO., LTD.
The small molecule drugs covered by the patents cited in this case are ⤷  Get Started Free and ⤷  Get Started Free .

Litigation Summary and Analysis: Headwater Research LLC v. Samsung Electronics Co., Ltd. (2:23-cv-00641)

Last updated: February 9, 2026


What is the case about?

Headwater Research LLC filed a patent infringement lawsuit against Samsung Electronics Co., Ltd., alleging that Samsung's devices infringe on patents owned by Headwater Research. The case is filed in the District of Utah and revolves around technology patents related to mobile communication or semiconductor processes. Specific patent details are not publicly disclosed in available filings, limiting precise analysis.

When was the case filed and what is the current status?

  • Filing Date: June 21, 2023
  • Docket Number: 2:23-cv-00641
  • Current Status: The case is in initial stages; no judge assignment or dispositive motions listed as of the latest docket update.

What are the key legal claims?

  • Patent Infringement: Headwater Research alleges Samsung's smartphones or semiconductor components infringe on patents related to wireless communications, chips, or integrated circuits.

  • Declaratory Judgment: Headwater requests a court ruling confirming its patent rights and declaring that Samsung's products infringe or violate its patents.

What are Samsung’s potential defenses?

  • Invalidity: Samsung may challenge the patents’ validity on grounds such as prior art or obviousness.

  • Non-infringement: Samsung might argue its products do not infringe the specific claims of the patents.

  • Patent Enforcement Timing: Samsung could claim that the patents are improperly enforced or that the suit is barred by prior agreements or licensing.

Legal landscape and relevant precedents

Patent litigation between technology giants often involves complex validity arguments and technical claim construction. The case's outcomes depend heavily on:

  • Whether the patents are valid and enforceable.

  • Whether Samsung's products operate within the scope of the patent claims.

While specific case precedents are not cited here due to case nascency, general case law emphasizes that patents must be novel, non-obvious, and properly claimed for infringement to hold.

Potential implications

  • If found infringing and valid, Samsung could face injunctions, damages, or licensing terms.

  • A ruling invalidating the patents could weaken Headwater Research’s enforcement position.

  • The case reflects ongoing patent disputes within the mobile device and semiconductor sectors, indicating heightened scrutiny of patent validity and scope.

Key jurisdictional and procedural points

  • The case resides in the District of Utah, where patent cases are governed by the Patent Local Rules, emphasizing early disclosure of asserted patents and infringement contentions.

  • No preliminary injunction motion has been filed as of the latest docket, suggesting early-stage litigation.


Key Takeaways

  • The case exemplifies patent enforcement efforts in the mobile and semiconductor sectors, with potential financial implications depending on the infringement and validity determinations.

  • Samsung’s defenses may include challenges to patent validity and product non-infringement; effectiveness depends on dispute-specific technical analysis.

  • Early procedural filings do not suffice to predict litigation outcomes, but they highlight ongoing patent disputes within the industry.

FAQs

1. What patents are involved in the case?
Specific patent details are not publicly disclosed yet, as the case is in early stages.

2. Could Samsung settle or license instead of fighting?
Possible, but no settlement or licensing discussions have been publicly reported.

3. How long does patent litigation in district courts typically last?
Average durations range from 18 to 36 months before trial; some cases settle earlier.

4. What is the importance of validity challenges?
Validating or invalidating patents affects enforceability; invalid patents cannot support infringement claims.

5. How does patent litigation affect technology development?
It can lead to license agreements, product redesigns, or delays, influencing innovation pathways.


Sources

  1. Court Docket, 2:23-cv-00641, District of Utah.
  2. Patent Local Rules, District of Utah.
  3. Industry reports on patent litigation trends (2022-2023).

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.